Contact Us
  Search
The Business Research Company Logo
Microbial Fermentation Technology Global Market Opportunities And Strategies To 2035
Published :May 2026
Pages :399
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Microbial Fermentation Technology Global Market Opportunities And Strategies To 2035

By Type (Medical, Industrial, Alcohol Beverages, Food And Feed Products), By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules), By End Users (Bio-Pharmaceutical Companies, Contract Research Organizations (CROS), Contract Manufacturing Organization (CMOS) And Contract Development And Manufacturing Organization (CDMOS), Food And Beverage Manufacturers, Industrial Biotechnology Companies, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2035

Microbial Fermentation Technology Market Definition

Microbial fermentation technology is a biotechnological process that uses microorganisms such as bacteria, yeast, or fungi to convert organic substrates (such as sugars, starches, or biomass) into valuable products under controlled conditions. These products can include enzymes, pharmaceuticals, biofuels, organic acids, alcohols, amino acids, and food ingredients. The primary purpose of microbial fermentation technology is to enable efficient, scalable, and sustainable production of biologically derived products. The microbial fermentation technology market consists of sales, by entities (organizations, sole traders, or partnerships), of products, technologies, and services that utilize microorganisms such as bacteria, yeast, and fungi to produce commercially valuable compounds through controlled fermentation processes. This market includes revenues generated from fermentation equipment, culture media, microbial strains, process technologies, and contract fermentation services used across medical, industrial, food and beverage, feed, and bio-based chemical applications.
Research Expert

Book your 30 minutes free consultation with our research experts

Microbial Fermentation Technology Global Market Opportunities And Strategies To 2035 Market Size and growth rate 2025 to 2030: Graph

Microbial Fermentation Technology Market Size

The global microbial fermentation technology market reached a value of nearly $40,760 million in 2025, having grown at a compound annual growth rate (CAGR) of 7.1% since 2020. The market is expected to grow from $40,760 million in 2025 to $55,431.9 million in 2030 at a rate of 6.3%. The market is then expected to grow at a CAGR of 5.6% from 2030 and reach $72,856.8 million in 2035. Growth in the historic period resulted from rise in demand for personalized medicine, growing adoption in food and beverage, rising consumer demand for natural and organic food products and increasing demand for alternative proteins. Factors that negatively affected growth in the historic period were strict government regulations and risk of contamination during fermentation. Going forward, expansion of chronic and infectious diseases, advancements in bioprocess automation, rising demand for biopharmaceuticals and expanding use of probiotics, postbiotics, and functional microbiome will drive the growth. Factor that could hinder the growth of the microbial fermentation technology market in the future include high production costs, difficulty in scaling up production and impact of trade war and tariff.

Microbial Fermentation Technology Market Segmentation

The microbial fermentation technology market is segmented by type, by application and by end user.

By Type –
The microbial fermentation technology market is segmented by type into:
    • a) Medical
    • b) Industrial
    • c) Alcohol beverages
    • d) Food and feed products
The medical market was the largest segment of the microbial fermentation technology market segmented by type, accounting for 63.9% or $26,060.1 million of the total in 2025. Going forward, the medical segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by type, at a CAGR of 6.6% during 2025-2030.

By Application –
The microbial fermentation technology market is segmented by application into:
    • a) Antibiotics
    • b) Probiotics supplements
    • c) Monoclonal antibodies
    • d) Recombinant proteins
    • e) Biosimilars
    • f) Vaccines
    • g) Enzymes
    • h) Small molecules
The antibiotics market was the largest segment of the microbial fermentation technology market segmented by application, accounting for 31.3% or $12,741.8 million of the total in 2025. Going forward, the biosimilars segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by application, at a CAGR of 9.6% during 2025-2030.

By End User –
The microbial fermentation technology market is segmented by end user into:
  1. a) Bio-pharmaceutical companies
  2. b) Contract research organizations (CROS)
  3. c) Contract manufacturing organization (CMOS) and contract development and manufacturing organization (CDMOS)
  4. d) Food and beverage manufacturers
  5. e) Industrial biotechnology companies
  6. f) Academic and research institutes
The bio-pharmaceutical companies market was the largest segment of the microbial fermentation technology market segmented by end users, accounting for 33.1% or $13,491.6 million of the total in 2025. Going forward, the contract manufacturing organization (CMOs) and contract development and manufacturing organization (CDMOs) segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by end users, at a CAGR of 8.3% during 2025-2030.

By Geography - The microbial fermentation technology market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
Asia-Pacific was the largest region in the microbial fermentation technology market, accounting for 42.3% or $17,251.8 million of the total in 2025. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the microbial fermentation technology market will be Asia-Pacific and Eastern Europe where growth will be at CAGRs of 8.2% and 6.2% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 6.0% and 5.7% respectively.

Microbial Fermentation Technology Market Drivers

The key drivers of the microbial fermentation technology market include: Expansion Of Chronic And Infectious Diseases Expansion of chronic and infectious diseases is expected to be a key driver of the growth of the microbial fermentation technology market in the forecast period. Chronic conditions such as metabolic disorders, autoimmune diseases, and long-term infections require continuous access to biologically derived therapeutics, including antibiotics, vaccines, recombinant proteins, and biosimilars, many of which are produced through microbial fermentation. Infectious disease management further relies on rapid, scalable, and cost-effective production platforms to meet fluctuating demand for antimicrobial agents and preventive solutions. Microbial fermentation enables high-volume, consistent manufacturing of these biologics while supporting process scalability and regulatory compliance. The expansion of chronic and infectious diseases growth contribution during the forecast period in 2025 is 1.5%.

Microbial Fermentation Technology Market Restraints

The key restraints on the microbial fermentation technology market include: High Production Costs High production costs are restricting the growth of the microbial fermentation technology market during the forecast period. Microbial fermentation processes require substantial capital investment in bioreactors, sterilization systems, process automation, and downstream purification infrastructure. In addition, ongoing operational expenses related to energy consumption, fermentation media, microbial strain maintenance, quality control, and waste management increase overall production costs. Maintaining sterile environments and ensuring batch consistency further add to operational complexity. These cost pressures can restrict adoption among small and mid-sized manufacturers and slow capacity expansion, particularly in cost-sensitive applications such as food, feed, and industrial biotechnology. Growth affected by the high production costs during the forecast period in 2025 is -2.0%.

Microbial Fermentation Technology Market Competitive Landscape

Major Competitors are:

  • Novonesis (Novozymes A/S)
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Cargill Inc.
  • Evonik Industries AG (Health & Care)
  • Other Competitors Include:

  • Ajinomoto Co Inc.
  • AGC Group
  • Amyris Inc.
  • Ginkgo Bioworks Inc.
  • Biovectra Inc.
  • Eclipse Ingredients
  • All G Foods
  • Angel Yeast Co., Ltd
  • Genexis Biotech
  • PT Bio Farma
  • Dao Foods International
  • Angel Yeast Indonesia (JV)
  • Ajinomoto Co., Inc.
  • Kirin Holdings Company, Limited
  • LG Chem
  • Intake Foods
  • CJ CheilJedang
  • Lesaffre
  • Formo
  • 21st.BIO
  • Arla Foods
  • Novozymes
  • Nutropy
  • Lonza Group AG
  • Sartorius AG
  • Abolis Biotechnologies
  • MOA Foodtech
  • HeiQ
  • BioTech Foods
  • Microferm Ltd
  • Koninklijke DSM N.V.
  • Evonik Industries AG
  • Biocon Ltd.
  • BASF SE
  • Thermo Fisher Scientific Inc.
  • AB Biotek
  • Evonik Industries AG
  • Biocon Ltd.
  • BASF SE
  • Lysterra LLC
  • Kerry Group plc
  • Roche Holding AG
  • Arsenale Bioyards
  • Novonesis
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • F. Hoffmann-La Roche AG
  • Archer Daniels Midland Company (ADM)
  • DuPont de Nemours, Inc.
  • Thermo Fisher Scientific Inc.
  • FermenteQ Innovations Inc.
  • Calysta
  • Smallfood
  • Geltor Inc.
  • Biofect Innovations
  • Pfizer
  • Amgen
  • AstraZeneca
  • Bayer AG
  • Novartis AG
  • Cytiva
  • Merck & Co., Inc.
  • Cargill, Incorporated
  • ZymoChem Inc.
  • Conagen Inc.
  • MycoTechnology, Inc.
  • Amano Enzyme Inc.
  • Amyris, Inc.
  • Agvault LLC
  • Triplebar Bio Inc.
  • Liberation Bioindustries
  • Proventus Bioscience
  • LifeLore Pathways
  • 3Bar Biologics
  • Rizobacter
  • Biogened S.A.
  • BioZeus
  • Bionet
  • Cristália - Indústria Farmacêutica
  • Laboratorio Pasteur
  • Typcal
  • AION Labs
  • Lifera
  • Eran Yona
  • SaudiVax
  • Pluri Inc.
  • Sartorius AG
  • BioLineRx Ltd
  • Kerry Group
  • Evonik
  • Cargill
  • Lonza Group
  • Novel Foods Group
  • May & Baker Nigeria Plc
  • Fidson Healthcare Plc
  • CapeBio SA
  • Biovac
  • Immobazyme
  • Sawubona Mycelium
  • BASF – Egypt
  • Need data on a specific region in this market?

    Opportunities And Recommendations In The Microbial Fermentation Technology Market

    Opportunities – The top opportunities in the microbial fermentation technology markets segmented by type will arise in the medical segment, which will gain $9,833.7 million of global annual sales by 2030. The top opportunities in the microbial fermentation technology markets segmented by application will arise in the antibiotics segment, which will gain $3,329.3 million of global annual sales by 2030. The top opportunities in the microbial fermentation technology markets segmented by end users will arise in the bio-pharmaceutical companie segment, which will gain $4,690.7 million of global annual sales by 2030. The microbial fermentation technology market size will gain the most in China at $4,532.1 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the microbial fermentation technology companies to focus on precision fermentation systems for scalable beverage manufacturing, focus on industrial partnerships to scale functional food and feed ingredients, focus on pilot-scale infrastructure to bridge innovation and commercialization, focus on bio-based chemical platforms through technology collaboration, focus on medical and biopharmaceutical fermentation platforms, focus on direct and regionalized distribution channels, focus on value-linked and segmented pricing models, focus on credibility-led technical promotion, focus on application-driven and account-based promotion, focus on scalable food and feed fermentation solutions, focus on industrial bio-based chemical and enzyme applications.
    Chat with us